FDAFDA · Food and drugs·Recall number D-0648-2024
Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01
Published September 4, 2024 · Recall initiated: August 21, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- USA nationwide.
- UPC
- 0368180423089
- Lot
- Lot #: F201517, Exp 11/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.